Stay updated on ATH-1017 in Alzheimer's: Mild to Moderate Clinical Trial
Sign up to get notified when there's something new on the ATH-1017 in Alzheimer's: Mild to Moderate Clinical Trial page.

Latest updates to the ATH-1017 in Alzheimer's: Mild to Moderate Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 to the history; removed Revision: v3.4.1 and the prior government-funding notice from the history. These changes are administrative and affect only the history view, not trial data.SummaryDifference0.7%

- Check21 days agoChange DetectedA site-wide notice about government funding and opening status appears on the page, and the revision tag updated to v3.4.1 (replacing v3.4.0); To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check28 days agoChange DetectedThe update adds a glossary option and uses color-coded highlights with a new revision tag (v3.4.0) to denote changes in the study history; these are presentation and navigation improvements rather than substantive content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check42 days agoChange DetectedAdded Revision: v3.3.4 to the history and removed Revision: v3.3.3 from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision tag 'Revision: v3.3.3' was added to the history. The 'HHS Vulnerability Disclosure' link and the prior revision tag 'Revision: v3.3.2' were removed.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page history now shows Revision: v3.3.2 added and Revision: v3.3.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ATH-1017 in Alzheimer's: Mild to Moderate Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ATH-1017 in Alzheimer's: Mild to Moderate Clinical Trial page.